Thyrocare Technologies: Board Meeting Intimation for Board Meeting To Consider, Inter Alia, Audited Financial Results For FY 2018-19 (Stand-Alone And Consolidated), Payment Of Dividend And Issue Of Stock Options To Employees -Intimation Under Regulation 29 (1) (A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2019 inter alia to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to intimate that a meeting of our Board of Directors of the Company will be held on Saturday May 18 2019 at the Corporate Office of the Company inter alia to consider and approve Stand-alone and Consolidated Audited Financial Results of the Company for the quarter / financial year ended March 31 2019 to consider recommending dividend if any for the financial year 2018-19 and to consider granting of Employee Stock Options for the financial year ended March 31 2019.

Intimation of the above meeting of the Board of Directors is also being published in newspapers as required under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.